Skip to main content
. 2020 Sep 25;6:46. doi: 10.1038/s41523-020-00188-3

Fig. 2. Proportion of patients in each genomic risk category according to age.

Fig. 2

a EndoPredict, b MammaPrint, c Oncotype DX (traditional recurrence risk categories), d Oncotype DX (TAILORx recurrence risk categories). Patients aged ≤40 years were predominantly classified as intermediate to high-risk by Oncotype DX (traditional cut-off value of >18:61%; TAILORx threshold of >11:86%) or as high-risk by MammaPrint (65%) and EndoPredict (68%). In contrast, patients aged >40 years were more likely to be assigned a low-risk category (59% when using the traditional threshold of Oncotype, 56% by MammaPrint, and 51% by EndoPredict). Error bars are set to 5%.